Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial

Fig. 2

Mean change in CRT from baseline to the last visit. In comparison between two groups, general linear model was constructed as well for variance analysis with baseline CRT adjusted. Mean gains in CRT from baseline to week 52 were similar between two groups (P = 0.3999). Change in CRT from baseline to week 52 were normally distributed (P > 0.05 in Shapiro-Wilk tests in both groups). Mean ± SD change in CRT from baseline to week 52 was − 280.6 ± 181.4 μm in IVR group, − 321.1 ± 240.5 μm in IVR + Laser group

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us